C12N 15/87
Introduction of foreign genetic material using processes not otherwise provided for
Official title: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
C12N15/87 (Introduction of foreign genetic material using processes not otherwise provided for) appears on 6,121 US grants and 12,034 published applications in this corpus.
Search patents in C12N- Granted patents
- 6,121
- Published applications
- 12,034
- Assignees
- 3,401
- Inventors
- 19,309
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 9 | 0 |
| 1989 | 13 | 0 |
| 1990 | 18 | 0 |
| 1991 | 14 | 0 |
| 1992 | 19 | 0 |
| 1993 | 27 | 0 |
| 1994 | 25 | 0 |
| 1995 | 24 | 0 |
| 1996 | 52 | 0 |
| 1997 | 92 | 0 |
| 1998 | 156 | 0 |
| 1999 | 154 | 0 |
| 2000 | 126 | 0 |
| 2001 | 144 | 47 |
| 2002 | 133 | 218 |
| 2003 | 126 | 522 |
| 2004 | 101 | 272 |
| 2005 | 72 | 302 |
| 2006 | 117 | 256 |
| 2007 | 100 | 150 |
| 2008 | 118 | 172 |
| 2009 | 88 | 194 |
| 2010 | 110 | 214 |
| 2011 | 111 | 228 |
| 2012 | 107 | 225 |
| 2013 | 125 | 259 |
| 2014 | 152 | 317 |
| 2015 | 163 | 312 |
| 2016 | 200 | 362 |
| 2017 | 229 | 385 |
| 2018 | 211 | 505 |
| 2019 | 283 | 679 |
| 2020 | 330 | 758 |
| 2021 | 328 | 791 |
| 2022 | 403 | 884 |
| 2023 | 394 | 957 |
| 2024 | 395 | 1087 |
| 2025 | 513 | 1071 |
| 2026 | 328 | 867 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for use in treating dystrophic epidermolysis bullosa6 Oct 2026US 12,751,974 B2Osaka University
- Methods and compositions of chondrisomes6 Oct 2026US 12,751,977 B2Children's Medical Center Corporation
- Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene6 Oct 2026US 12,752,019 B2Precision BioSciences, Inc.
- Mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy6 Oct 2026US 12,753,220 B2Cellectis
- Electroporation device and method for producing cells with introduced foreign substance6 Oct 2026US 12,753,383 B2National University Corporation Toyohashi University of Technology
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Methods of preventing on-target genotoxicity induced by nucleases8 Oct 2026US 2026/0306552 A1Chu De Bordeaux
- Process and formulation of lipid nanoparticles8 Oct 2026US 2026/0306584 A1Translate Bio, Inc.
- Base editing approaches to treat abca4-associated stargardt disease8 Oct 2026US 2026/0306670 A1Massachusetts Eye and Ear Infirmary
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,541US 5,661,016 AGenPharm International, Inc. · 1997